Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,187,758
+$405,863 QoQ
Shares Held
8,694
+6.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,894
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Joel Isaacson & Co., LLC holds $52,580,622 across 13 Drug Manufacturers - General names. ABBV ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
79,396 | $20,164,202 | |
| 2 | LLY |
ELI LILLY & Co
|
11,698 | $14,030,933 | |
| 3 | MRK |
Merck & Co., Inc.
|
43,718 | $5,617,763 | |
| 4 | AMGN |
Amgen Inc
|
8,040 | $2,911,444 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
8,694 | $2,187,758 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
37,637 | $2,168,643 | |
| 7 | PFE |
Pfizer Inc
|
86,319 | $2,078,561 | |
| 8 | NVS |
Novartis AG
|
6,486 | $1,016,485 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,187,758 | 8,694 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,781,895 | 8,193 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,848,941 | 8,092 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,670,098 | 7,213 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,257,204 | 6,773 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,402,526 | 6,694 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,101,206 | 6,197 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,220,623 | 6,181 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $1,076,802 | 6,278 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $1,204,591 | 6,615 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $1,036,749 | 6,690 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $964,418 | 6,470 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $871,298 | 6,467 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $1,046,104 | 6,564 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $1,068,080 | 6,609 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $958,125 | 7,139 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,030,919 | 6,731 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,027,939 | 6,341 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $836,230 | 6,176 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $666,420 | 6,178 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $688,117 | 6,109 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $716,524 | 6,621 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $709,440 | 6,621 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $574,152 | 6,555 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $632,966 | 6,447 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $458,892 | 6,023 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||